Merck: An agreement was reached with the US Department of Commerce to delay implementation of the tariffs for three years. Merck is expanding drug access channels and reducing drug costs for Americans. Among them, Genovi, Genoda, and Genoda extended-release tablets will be supplied to eligible American patients at cash prices. The price is about 30% off the current list price. The company also promised to invest more than $70 billion in the US.

Merck: An agreement was reached with the US Department of Commerce to delay implementation of the tariffs for three years. Merck is expanding drug access channels and reducing drug costs for Americans. Among them, Genovi, Genoda, and Genoda extended-release tablets will be supplied to eligible American patients at cash prices. The price is about 30% off the current list price. The company also promised to invest more than $70 billion in the US.